For the primary time, Medicare will cowl GLP-1s for obesity-related weight reduction, with out every other medical situations.
Beginning Wednesday, eligible Medicare beneficiaries can obtain GLP-1s for weight problems for $50 monthly by prescription. Medicare is the first federal medical health insurance program within the U.S. for people 65 and older.
Federal guidelines ban Medicare Half D — which helps cowl prescription drug prices — from masking medicine solely to deal with weight problems, however a brand new federal pilot bridge program accredited by Well being and Human Providers Secretary Robert F. Kennedy Jr. can be in impact till Dec. 31, 2027.
Lively ingredient in Ozempic, Wegovy might scale back danger of Alzheimer’s illness: Research
This transfer might dramatically broaden entry to Eli Lilly’s Foundayo and Zepbound and Novo Nordisk’s Wegovy for seniors 65 and older in addition to different eligible Medicare enrollees.
Foundayo and Wegovy Tablet are day by day tablets. Wegovy and Zepbound are weekly injections that require refrigeration.
A month provide of Wegovy will are available in 4 pre-filled pens whereas Zepbound can be delivered in a KwikPen, which holds 4 weekly doses in a single machine.
Single-dose Zepbound pens and Zepbound vials is not going to be lined by the bridge program.
Hollie Adams/Brendan McDermid/Reuters – PHOTO: A mixture picture reveals an injection pen of Zepbound, Eli Lilly’s weight reduction drug, and bins of Wegovy, made by Novo Nordisk.
“These therapies are a significant medical development, however too many seniors are presently unable to entry them as a consequence of excessive price,” Dr. Mehmet Oz, administrator of the Facilities for Medicare and Medicaid, mentioned in a press release final month. “The Medicare GLP-1 Bridge modifications that by making these drugs extra reasonably priced and accessible, whereas advancing our broader objective of serving to Individuals stay more healthy lives.”
An estimated 3.8 million beneficiaries might be eligible for this system, based on a KFF evaluation of 2023 Half D enrollment information that was printed Monday.
The federal government negotiated with the producers to scale back the value the federal government pays to $250 for a month’s provide and in return the businesses could have entry to the bigger affected person inhabitants. Every affected person pays a $50 copay in direction of the price of the medicine, however that co-pay is not going to go towards a person’s annual deductible.
Sufferers will first want prior authorization — prescribing clinicians will submit documentation proving the affected person meets strict physique mass index (BMI) and well being situation necessities. Meaning sufferers might want to anticipate the prescription to be accredited earlier than it may be stuffed.
Sufferers should have Physique Mass Index (BMI) of 35 or larger. If their BMI is 30-35, they should have sure varieties of coronary heart failure, laborious to manage blood or continual kidney illness.
If their BMI is 27-30, they should have prediabetes, historical past of coronary heart assault or stroke or blocked arteries within the arms or legs.
These necessities are extra restrictive than the FDA approval language or what personal insurance coverage firms require, which is a BMI of 30 or over.
Eli Lilly’s subsequent era weight reduction drug reveals promise, early trial outcomes counsel
Sufferers should additionally not have kind 2 diabetes, moderate-to-severe sleep apnea, or fatty liver illness as a result of their Medicare plan might already cowl GLP-1s.
“GLP-1s will be life-changing for sufferers managing weight problems and associated situations,” Chris Klomp, director of Medicare and chief counselor on the U.S. Division of Well being and Human Providers, mentioned in a press release final month.
“This demonstration is designed to make accessing these drugs less complicated, extra predictable, and extra constant throughout the Medicare program, which implies higher high quality of life for seniors and higher worth throughout the well being care system,” the assertion continued.
People will have the ability to fill their pre-approved prescriptions at native retail pharmacies and instantly by Novo Nordisk or Ely Lilly’s direct to shopper mail order pharmacies.